Solid Biosciences's market cap is currently ―. The company's EPS TTM is $-4.832; its P/E ratio is -2.95; Solid Biosciences is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-0.66. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	-	-	$ 517.00K	-	$ 0.00
Gross Profit	-	-	$ 517.00K	-	-
EBIT	$ -20.98M	$ -24.63M	$ -31.75M	$ -34.95M	$ -21.13M
EBITDA	$ -21.38M	$ -23.98M	$ -30.89M	$ -34.68M	$ -20.69M
Net Income Common Stockholders	$ -20.98M	$ -24.63M	$ -30.07M	$ -15.15M	$ -20.41M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 142.88M	$ 160.19M	$ 185.51M	$ 213.72M	$ 142.16M
Total Assets	$ 184.73M	$ 205.14M	$ 229.59M	$ 260.25M	$ 184.47M
Total Debt	$ 25.04M	$ 25.50M	$ 25.77M	$ 26.18M	$ 25.69M
Net Debt	$ -117.85M	$ -134.69M	$ -159.73M	$ -187.55M	$ -116.47M
Total Liabilities	$ 40.37M	$ 40.57M	$ 45.80M	$ 48.59M	$ 41.20M
Stockholders Equity	$ 144.36M	$ 163.73M	$ 183.79M	$ 211.67M	$ 143.28M
Cash Flow	-
Free Cash Flow	$ -18.28M	$ -28.00M	$ -28.50M	$ -35.34M	$ -21.27M
Operating Cash Flow	$ -17.90M	$ -27.46M	$ -28.00M	$ -34.48M	$ -20.43M
Investing Cash Flow	$ -24.64M	$ -48.23M	$ 37.26M	$ 66.10M	$ 14.91M
Financing Cash Flow	-	$ 2.62M	-	$ 74.74M	$ -1.00K

Currency in USD

Solid Biosciences Earnings and Revenue History

Income Statement >

Solid Biosciences Debt to Assets

Balance Sheet >

Solid Biosciences Cash Flow

Cash Flow >

Solid Biosciences Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing